CurrentRheuma
Get Weekly

Topic · page 7 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 241–280 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Lupus Sci Med

    Impact of an online lupus self-management programme in an established, population-based cohort of adults with diagnosed SLE: a mixed-methods study

    Research article

  2. Lupus Sci Med

    Reference intervals for aCL and anti-β2GPI IgAGM antibodies in a large health-inspection population: a foundational study for combined-isotype assay interpretation

    Cross-sectional study

  3. Arthritis Rheumatol

    B cell Maturation Antigen Targeted Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus and Systemic Sclerosis

    Research article

  4. Rheumatology (Oxford)

    Second delivery rates and recurrence of adverse pregnancy outcomes in women with systemic lupus erythematosus: a nationwide population-based cohort study

    Cohort study

  5. Lupus

    Factors associated with changes in self-efficacy in patients with systemic lupus erythematosus. Data from the almenara lupus cohort

    Cohort study

  6. Lupus

    Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteria

    Cohort study

  7. Lupus

    Lower-dose glucocorticoid therapy achieves comparable outcomes in Japanese patients with lupus nephritis

    Cohort study

  8. Arthritis Care Res (Hoboken)

    Hydroxychloroquine Use, Preeclampsia, and Preterm Delivery Complications in Systemic Lupus Erythematosus Pregnancies: Is There a Protective Effect?

    Cohort study

  9. Arthritis Care Res (Hoboken)

    Developing and Evaluating a Laboratory‐Based Frailty Index for the Prediction of Long‐Term Health Outcomes in Systemic Lupus Erythematosus

    Cohort study

  10. Lupus Sci Med

    Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort

    Cohort study

  11. Lupus Sci Med

    Controlling cardiovascular risk factors reduces progression of atherosclerosis in a multiethnic cohort of patients with lupus

    Cohort study

  12. Arthritis Rheumatol

    Increased Risk of Intrahepatic Cholestasis of Pregnancy in Women With Systemic Lupus Erythematosus Exposed to Azathioprine

    Cohort study

  13. Arthritis Rheumatol

    Identifying Systemic Lupus Erythematosus From Serum Proteomic Profiles Using Machine Learning and Genetic Risk Stratification

    Diagnostic or prognostic study

  14. Arthritis Rheumatol

    ANK1 and EPB41 Variants and The Risk of Glucocorticoid‐Induced Osteonecrosis

    Case-control study

  15. Arthritis Care Res (Hoboken)

    Real‐World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

    Cohort study

  16. Arthritis Care Res (Hoboken)

    The Association of Physical Function With Psychosocial Patient‐Reported Outcomes in People With Systemic Lupus Erythematosus

    Cross-sectional study

  17. Lupus

    Geographic distribution of mortality from systemic lupus erythematosus

    Research article

  18. Arthritis Care Res (Hoboken)

    Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/ EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up

    Cohort study

  19. Arthritis Care Res (Hoboken)

    Integrating Patient‐Reported Quality Measures in Systemic Lupus Erythematosus: Development of the American College of Rheumatology Implementation Guide

    Research article

  20. Ann Rheum Dis

    Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression

    Mechanistic study

  21. Lupus

    Treatment patterns and outcomes of first lupus nephritis episode over 25 years in two Latin American cohorts

    Cohort study

  22. Arthritis Rheumatol

    Kidney Hematopoietic Stem and Progenitor Cells Contribute to Myeloid Development and Pathology in Lupus Nephritis

    Mechanistic study

  23. Lupus Sci Med

    Evaluation of clinical, histological and biomarker response after initial therapy of lupus nephritis

    Cohort study

  24. Lupus Sci Med

    Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort

    Cohort study

  25. Lupus Sci Med

    Validity and applicability of machine learning models for systemic lupus erythematosus diagnosis

    Diagnostic or prognostic study

  26. Rheumatology (Oxford)

    High-sensitivity serum interferon-α and interferon-γ as immunometabolic mediators of metabolic syndrome in systemic lupus erythematosus

    Cross-sectional study

  27. Rheumatology (Oxford)

    Risk of systemic lupus erythematosus elevated years after testing positive for antinuclear antibodies: national cohort study in Denmark

    Cohort study

  28. RMD Open

    Early methylprednisolone pulses and prevention of long-term damage accrual in active systemic lupus erythematosus: a propensity score analysis of the Lupus–Cruces–Bordeaux cohort

    Cohort study

  29. Ann Rheum Dis

    A pathogenic gut lipoglycan drives systemic thromboinflammation in lupus nephritis

    Mechanistic study

  30. Arthritis Res Ther

    Interferon α-induced HERC6 provokes podocyte dysfunction via mitotic catastrophe in lupus nephritis

    Mechanistic study

  31. Arthritis Care Res (Hoboken)

    Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus—A Systematic Review and Meta‐Analysis

    Meta-analysis

  32. Rheumatology (Oxford)

    Efficacy of the Lupus-Cruces Nephritis protocol in different prognostic groups: a propensity score and cluster analysis

    Cohort study

  33. Lupus Sci Med

    Serum lipidomic and metabolomic signatures link epicardial adipose tissue to cardiovascular diseases in SLE: a post-hoc analysis

    Cohort study

  34. Arthritis Rheumatol

    TWEAK /Fn14 Signaling Drives Oxidative Cardiac Injury in Systemic Lupus Erythematosus: Evidence From Patient Biomarker Studies, Lupus Mouse Models, and Cardiomyocyte Assays

    Mechanistic study

  35. Lupus Sci Med

    Baseline characteristics of patients with SLE with and without lupus nephritis from the Latin American multiethnic GLADEL 2.0 cohort

    Cross-sectional study

  36. Arthritis Rheumatol

    Multi‐Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis

    Mechanistic study

  37. Rheumatology (Oxford)

    Predictors of relapse and drivers of damage in SLE-associated thrombocytopenia: a long-term cohort study with comparative literature analysis

    Cohort study

  38. Arthritis Rheumatol

    Single‐Cell Level Characterization of B Cell Depletion and Repopulation Following Rituximab in Systemic Lupus Erythematosus

    Mechanistic study

  39. Arthritis Rheumatol

    Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications

    Cross-sectional study

  40. Arthritis Res Ther

    The DHCQ/HCQ metabolic ratio and CYP2C8 Genotype are associated with lipid profile improvement in systemic lupus erythematosus patients treated with hydroxychloroquine

    Cohort study

All 1,848 Briefs in ExploreShowing Briefs 241–280 of 1,848, newest first